Explore How We Can Work Together
Who I work with
Ingredient manufacturers
Corporate innovation teams
FoodTech startups
Venture partners & regulatory advisors
Working on:
• dietary fiber
• plant-based ingredients
• fermentation-derived ingredients
• biotics & microbiome technologies
When Teams Reach Out
If you are here, you are likely facing one of these
Preparing a product, claim, or clinical strategy — but not fully confident it will hold in the market
Expanding a portfolio — but unclear how to differentiate between similar ingredients
Scaling commercial activity — but customers don’t clearly understand why to choose your solution
Getting repeated questions from partners, investors, or clients that are difficult to answer clearly
Decisions made now become difficult to change later
If not clarified:
• claims don’t translate into product decisions
• differentiation is lost across similar solutions
• pricing and positioning weaken over time
• credibility is harder to sustain with partners and regulators
Ways to Work Together
-
A focused working session to review your current approach and identify where clarity is missing.
Best for:
early-stage decisions, validation, or quick alignmentOutcome:
clear next steps before committing further -
A structured deep dive to clarify:
• what to build
• what to claim
• what to validate
• how to differentiateOutcome:
a concise strategic brief with:key risks
differentiation opportunities
priority actions
-
Ongoing support for teams working through complex decisions over time.
Aligning:
• science
• claims
• regulatory direction
• commercial positioning -
Microbiome training
Deep dive into gut microbiome science applied to food innovation.
Best for:
teams or professionals building foundational understanding
When Ingredient Adoption Stalls
-
Functional ingredient sales can stall even when the ingredient performs well technically. The barrier may sit in customer targeting, application fit, scientific evidence, positioning, commercial messaging, distributor execution or internal alignment between R&D, marketing and sales.
When customers stop progressing without explaining why, generating more leads or changing the value proposition may not solve the problem. The first priority is to identify where ingredient adoption is breaking down and what is preventing customers from moving forward.
-
A successful technical trial does not necessarily mean an ingredient is ready for commercial adoption. The customer may still face unresolved questions around cost, evidence, claims, application fit, supply, internal priorities or the business case for switching.
Silence is therefore useful information. Understanding where the customer stopped in the buying journey—and what information or confidence was missing—can reveal barriers that technical trial results alone will not show.
-
Start by identifying where customers are dropping out between interest, testing and commercial adoption. Then examine the barriers surrounding that stage rather than assuming the ingredient itself is the problem.
These may include technical performance, evidence, cost-in-use, regulatory requirements, customer targeting, positioning, distributor effectiveness or missing information during the buying process. Looking across these factors helps distinguish an ingredient problem from a commercial, customer or organizational problem—and shows where intervention is most likely to accelerate adoption.
-
Functional ingredient sales cycles are naturally complex because customers must evaluate technical performance, evidence, regulatory requirements, economics, supply and internal stakeholder needs.
They can often be shortened by targeting customers and applications with a strong reason to adopt, anticipating the information required at each decision stage, and connecting technical evidence to a clear commercial value proposition. Application support and strong documentation help, but the greatest gains come from identifying where opportunities repeatedly slow down and addressing that specific barrier.
-
Before changing the positioning, determine why adoption is slow. Stronger differentiation will not solve a problem caused by the wrong target customers, insufficient evidence, application barriers, weak distributor execution or gaps in the buying journey.
Once the barrier is understood, differentiation can connect the ingredient's functionality and evidence to the applications, customer needs and commercial outcomes where it creates the greatest value. The objective is not simply to make the ingredient sound different, but to make its reason for adoption clearer.
-
Rather than treating R&D, marketing and sales as separate activities, ingredient companies can use customer intelligence as a shared input for deciding what evidence to generate, which applications to prioritize, what information customers need and where commercial resources should focus. This creates a stronger feedback loop between science and market opportunity.